1-O-Hexadecyl-2-O-docosahexaenoyl-sn-glycero-3-phosphorylcholine

1-O-Hexadecyl-2-O-docosahexaenoyl-sn-glycero-3-phosphorylcholine is an endogenous metabolite present in Urine that can be used for the research of Obesity[1][2].

Product Specifications

CAS Number

[132213-85-5]

Product Name Alternative

PC (O-16:0/22:6 (4Z,7Z,10Z,13Z,16Z,19Z) )

UNSPSC

12352211

Hazard Statement

H302, H315, H319, H331, H336, H351, H361, H372

Target

Endogenous Metabolite

Type

Reference compound

Related Pathways

Metabolic Enzyme/Protease

Applications

Metabolism-protein/nucleotide metabolism

Field of Research

Metabolic Disease

Assay Protocol

https://www.medchemexpress.com/1-o-hexadecyl-2-o-docosahexaenoyl-sn-glycero-3-phosphorylcholine.html

Concentration

12.62 mM * 100 μL in Ethanol with 0.1% BHT

Purity

99.6

Solubility

10 mM in DMSO

Smiles

CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)O[C@H](COCCCCCCCCCCCCCCCC)COP(=O)([O-])OCC[N+](C)(C)C

Molecular Formula

C46H82NO7P

Molecular Weight

792.12

Precautions

H302, H315, H319, H331, H336, H351, H361, H372

References & Citations

[1]Cho K, et al. Combined untargeted and targeted metabolomic profiling reveals urinary biomarkers for discriminating obese from normal-weight adolescents. Pediatr Obes. 2017 Apr;12 (2) :93-101.|[2]Lee N, et al. Endogenous toxic metabolites and implications in cancer therapy. Oncogene. 2020 Aug;39 (35) :5709-5720.